The weekly litigation news digest is live. Subscribe now

Injectable Composition And Use Of Said Composition - EP4232106

The patent EP4232106 was granted to Innate on Feb 12, 2025. The application was filed on Oct 25, 2021 under application number EP21807254A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4232106

INNATE
Application Number
EP21807254A
Filing Date
Oct 25, 2021
Status
Granted And Under Opposition
Jan 10, 2025
Publication Date
Feb 12, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BUDDE SCHOUNov 12, 2025BUDDE SCHOUADMISSIBLE
ALBOMEDNov 11, 2025LICHTI PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONWO2023066856
INTERNATIONAL-SEARCH-REPORTCN108578784
INTERNATIONAL-SEARCH-REPORTWO2020104915
OPPOSITIONCN108261341
OPPOSITIONCN108578784
OPPOSITIONEP2570118
OPPOSITIONFR2979539
OPPOSITIONUS2011104225
OPPOSITIONUS2012121534
OPPOSITIONUS2012237610
OPPOSITIONUS2017216414
OPPOSITIONWO0174781
OPPOSITIONWO03041724
OPPOSITIONWO2014172784
OPPOSITIONWO2017053339

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents